Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review

H P Adams Jr

Back

Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review

Journal article

Peer reviewed

Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review

H P Adams Jr

Angiology, Vol.41(11 Pt 2), pp.1010-1016

11/1990

PMID: 2248423

View Online

Abstract

Cerebral arterial vasospasm and infarction is the leading cause of death and disability among patients who reach a major medical center after aneurysmal subarachnoid hemorrhage (SAH). Recent evidence suggests that two calcium antagonists, nimodipine or nicardipine, may be useful in preventing this important complication of SAH. This paper reviews the current status of these two calcium antagonists in the management of SAH.

Cerebral Infarction - drug therapy

Ischemic Attack, Transient - drug therapy

Humans

Calcium Channel Blockers - therapeutic use

Nicardipine - therapeutic use

Intracranial Aneurysm - complications

Subarachnoid Hemorrhage - complications

Nimodipine - therapeutic use

Ischemic Attack, Transient - etiology

Cerebral Infarction - etiology

Subarachnoid Hemorrhage - etiology

Intracranial Aneurysm - drug therapy

Subarachnoid Hemorrhage - drug therapy

Details

Title: Subtitle: Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review
Creators: H P Adams Jr - Department of Neurology, University of Iowa, Iowa City
Resource Type: Journal article
Publication Details: Angiology, Vol.41(11 Pt 2), pp.1010-1016
Publisher: United States
PMID: 2248423
ISSN: 0003-3197
eISSN: 1940-1574
Grant note: N01-NS-2326, TO 2 / NINDS NIH HHS N01-NS-2329, TO1 / NINDS NIH HHS
Language: English
Date published: 11/1990
Academic Unit: Neurology; Iowa Neuroscience Institute
Record Identifier: 9984020893102771

Metrics

24 Record Views

13 Times Cited - Web of Science